RecruitingPhase 3NCT04047628
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
St Louis, MO · +22 more sites
Multiple Sclerosis clinical trials in St Louis, MO
16 recruiting multiple sclerosis studies with a site in St Louis, MO.
RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
St Louis, MO · +18 more sites
RecruitingPhase 3NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
St Louis, MO · +25 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
City of Saint Peters, MO · Creve Coeur, MO · Kansas City, MO · +48 more sites
RecruitingPhase 2NCT05104983
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Sponsor: Darcy Krueger
St Louis, MO · +10 more sites
RecruitingPhase 2NCT06782490
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Sponsor: Celgene
St Louis, MO · +15 more sites
RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
St Louis, MO · +40 more sites
RecruitingPhase 1 / Phase 2NCT07477639
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Sponsor: Tr1X, Inc.
St Louis, MO · +7 more sites
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
St Louis, MO · +43 more sites
RecruitingPhase 1NCT07224373
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Sponsor: AstraZeneca
St Louis, MO · +8 more sites
RecruitingPhase not listedNCT07758270
Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase not listedNCT07115017
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 1NCT07295847
A Study of AZD0120 in Autoimmune Diseases
Sponsor: AstraZeneca
St Louis, MO · +7 more sites
RecruitingPhase not listedNCT05676099
TSC Biosample Repository and Natural History Database
Sponsor: National Tuberous Sclerosis Association
Kansas City, MO · St Louis, MO · +22 more sites
RecruitingPhase 2NCT06735248
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
Sponsor: ModernaTX, Inc.
Ozark, MO · St Louis, MO · +6 more sites
RecruitingPhase not listedNCT06591429
Smoldering Inflammation in MS
Sponsor: Washington University School of Medicine
St Louis, MO
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.